From the 4/17 announcement:
MT. KISCO, N.Y., April 17, 2017 (GLOBE NEWSWIRE) -- ImmuDyne, Inc. (OTCQB:IMMD) (“ImmuDyne” or the “Company”), a leader in the development and marketing of OTC healthcare products, has been informed by OTC Markets Group the company will have until May 15, 2017 to file its Annual Report on Form 10K (prior to OTC Markets taking any action with respect to the company).
ImmuDyne currently expects to finalize its financial results and file its Annual Report on Form 10-K with the SEC as soon as practicable and further expects that the financial information contained in the Form 10-K will be consistent in all material respects with the financial results reported in our press release dated March 6, 2017. Based on the review and analysis conducted to date, no material adjustments, restatement or other revisions to previously issued financial statements of the Company are currently expected to be required.
'expects the financial information ....will be consistent in all material respects with the financial results reported 3/6. Based on review and analysis no material adjustments, restatement or other revisions are expected to be required.' This is important. IMMD and many OTC companies take all statutory time they need to file. Mark is a perfectionist in this area and remember there is no VP Fin, Controller or other such person to assist. Investor have nothing to worry about.
